23 Aggregation of marginal gains in the lung cancer pathology pathway: From acquisition of biopsy to the availability of a clinically relevant cellular pathology report
Taylor, Siobhan Raghami, Fatemah King, Hannah Steer, Henry Knight, Jiyoon
Taylor, Siobhan
Raghami, Fatemah
King, Hannah
Steer, Henry
Knight, Jiyoon
Date
2025-02-28
Journal Title
Subject
Type
Conference Abstract
Collections
Abstract
No abstract available
The reliable availability of a cellular pathology report at lung cancer MDTs is critical for smooth and rapid diagnostic pathways. Delays and variability in processing times may arise from multiple interdependent parts of the pathway, including biopsy timings and location, human factors, intra/inter-hospital transport, laboratory administration and laboratory sample processing.
The reliable availability of a cellular pathology report at lung cancer MDTs is critical for smooth and rapid diagnostic pathways. Delays and variability in processing times may arise from multiple interdependent parts of the pathway, including biopsy timings and location, human factors, intra/inter-hospital transport, laboratory administration and laboratory sample processing.
Citation
Taylor, S., Raghami, F., King, H., Knight, J., & Steer, H. (2025). 23 Aggregation of marginal gains in the lung cancer pathology pathway: From acquisition of biopsy to the availability of a clinically relevant cellular pathology report. Lung Cancer, 200, 108134.